ABDX
COM:ABINGDONHEALTH
Abingdon Health
- Stock
Last Close
7.25
22/11 15:15
Market Cap
143.03K
Beta: -
Volume Today
131.89K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '18 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 397.79K - | 592.88K 49.04% | 592.88K 0% | 4.21M 610.26% | 431.50K 89.75% | 385K 10.78% | ||
average payables | 323.38K - | 941.76K 191.23% | 941.76K 0% | 6.61M 601.72% | 3.55M 46.34% | 858K 75.80% | ||
average receivables | 3.34M - | 891K 73.31% | ||||||
book value per share | 0.06 - | 0.03 54.83% | 0.03 0% | 0.02 23.00% | 0.01 55.13% | 0.01 25.43% | ||
capex per share | -0.00 - | -0.02 1,625.33% | -0.02 0% | -0.00 84.93% | -0.00 80.19% | 0.00 126.05% | ||
capex to depreciation | -0.33 - | -0.40 21.08% | -0.40 0% | -0.46 15.23% | -0.21 55.45% | 0.10 146.53% | ||
capex to operating cash flow | 0.11 - | -0.79 847.90% | -0.79 0% | 0.10 112.39% | -0.17 275.11% | -0.02 85.63% | ||
capex to revenue | -0.04 - | -0.32 650.53% | -0.32 0% | -0.27 15.46% | -0.04 85.52% | 0.01 117.22% | ||
cash per share | 0.01 - | 0.05 406.64% | 0.05 0% | 0.01 82.02% | 0.01 29.49% | 0.00 55.60% | ||
days of inventory on hand | 210.30 - | 351.65 67.21% | 351.65 0% | 30.33 91.38% | 60.96 101.00% | 65.54 7.52% | ||
days payables outstanding | 223.08 - | 655.34 193.77% | 655.34 0% | 159.70 75.63% | 376.67 135.87% | 89.91 76.13% | ||
days sales outstanding | 64.43 - | |||||||
debt to assets | 0.08 - | 0.07 16.60% | 0.43 531.31% | 0.43 0% | 0.10 76.90% | 0.17 67.74% | 0.14 15.63% | |
debt to equity | 0.10 - | 0.08 15.68% | 1.73 1,991.77% | 1.73 0% | 0.20 88.50% | 0.34 70.17% | 0.32 5.20% | |
dividend yield | ||||||||
earnings yield | -0.01 - | -0.03 167.73% | -0.07 115.31% | -0.66 821.29% | -0.09 85.73% | -0.04 56.98% | ||
enterprise value | 93.52K - | 100.60M 107,470.57% | 101.33M 0.73% | 47.26M 53.36% | 30.96M 34.49% | 34.27M 10.68% | 30.84M 9.99% | |
enterprise value over ebitda | -91.22 - | 125.12 237.16% | 58.36 53.36% | -2.78 104.76% | -12.48 348.79% | -33.67 169.84% | ||
ev to operating cash flow | -110.76 - | 48.36 143.66% | 22.56 53.36% | -4.00 117.74% | 37.53 1,038.14% | -18.59 149.54% | ||
ev to sales | 44.18 - | 19.36 56.18% | 9.03 53.36% | 10.92 20.97% | 8.47 22.43% | 5.03 40.65% | ||
free cash flow per share | -0.01 - | 0.00 143.33% | 0.00 0% | -0.03 742.77% | 0.00 108.53% | -0.01 324.35% | ||
free cash flow yield | -0.01 - | 0.00 143.33% | 0.01 115.31% | -0.26 2,954.74% | 0.02 107.82% | -0.05 362.66% | ||
graham net net | -0.00 - | -0.04 1,898.56% | -0.04 0% | -0.01 64.84% | 0.00 109.10% | -0.00 205.42% | ||
graham number | 0.14 - | 0.15 9.97% | 0.15 0% | 0.19 26.38% | 0.05 73.57% | 0.03 47.65% | ||
income quality | 0.72 - | -0.62 186.17% | -0.62 0% | 0.36 158.61% | -0.26 172.69% | 1.31 593.37% | ||
intangibles to total assets | 0.67 - | 0.62 7.22% | 0.07 88.49% | 0.07 0% | 0.00 96.03% | 0.01 426.77% | 0.10 603.88% | |
interest coverage | -62.21 - | -51.47 17.27% | -51.44 0.05% | -312 506.48% | -49.63 84.09% | -24.09 51.46% | ||
interest debt per share | 0.01 - | 0.05 816.80% | 0.05 0% | 0.00 90.79% | 0.00 22.43% | 0.00 28.76% | ||
inventory turnover | 1.74 - | 1.04 40.20% | 1.04 0% | 12.04 1,059.53% | 5.99 50.25% | 5.57 6.99% | ||
invested capital | 0.10 - | 0.08 15.68% | 1.73 1,991.77% | 1.73 0% | 0.20 88.50% | 0.34 70.17% | 3.25M 960,576,641.90% | |
market cap | 100.96M - | 100.96M 0% | 46.89M 53.55% | 32.08M 31.59% | 36.48M 13.73% | 31.24M 14.39% | ||
net current asset value | 591.42K - | 997.58K 68.68% | -1.04M 203.78% | -1.04M 0% | 4.62M 546.16% | 1.71M 62.98% | 707K 58.65% | |
net debt to ebitda | 0.33 - | 0.46 39.06% | 0.46 0% | 0.10 78.06% | 0.81 704.83% | 0.43 47.13% | ||
net income per share | -0.01 - | -0.04 167.73% | -0.04 0% | -0.07 107.44% | -0.01 84.43% | -0.00 63.25% | ||
operating cash flow per share | -0.01 - | 0.02 330.69% | 0.02 0% | -0.03 221.57% | 0.00 111.32% | -0.01 281.29% | ||
payables turnover | 1.64 - | 0.56 65.96% | 0.56 0% | 2.29 310.36% | 0.97 57.60% | 4.06 318.93% | ||
receivables turnover | 5.66 - | |||||||
research and ddevelopement to revenue | ||||||||
return on tangible assets | -0.45 - | -0.33 26.26% | -0.33 0% | -1.67 404.25% | -0.58 65.38% | -0.28 51.75% | ||
revenue per share | 0.02 - | 0.05 129.88% | 0.05 0% | 0.01 82.18% | 0.01 36.86% | 0.02 51.32% | ||
roe | -0.21 - | -1.23 492.72% | -1.23 0% | -3.31 169.40% | -1.15 65.31% | -0.57 50.72% | ||
roic | -0.18 - | -0.38 116.35% | -0.38 0.05% | -2.51 562.60% | -0.80 68.17% | -0.42 47.46% | ||
sales general and administrative to revenue | 1.33 - | 1.50 13.16% | 1.50 0% | 2.34 56.05% | 1.29 44.94% | 0.83 35.96% | ||
shareholders equity per share | 0.06 - | 0.03 54.83% | 0.03 0% | 0.02 23.00% | 0.01 55.13% | 0.01 25.43% | ||
stock based compensation to revenue | 0.01 - | 0.01 53.16% | 0.01 0% | 0.08 1,076.33% | 0.01 91.50% | 0.01 13.03% | ||
tangible asset value | 1.21M - | 1.56M 29.39% | 1.97M 25.92% | 1.97M 0% | 6.40M 224.59% | 2.92M 54.36% | 1.72M 41.18% | |
tangible book value per share | 0.02 - | 0.02 25.92% | 0.02 0% | 0.02 6.83% | 0.01 56.23% | 0.01 41.31% | ||
working capital | 1.05M - | 1.39M 33.22% | 197.32K 85.85% | 197.32K 0% | 5.63M 2,755.25% | 2.64M 53.11% | 1.72M 34.75% |
All numbers in GBP (except ratios and percentages)